Sponsor:
Kurt Weiss
Code:
NCT04719156
Conditions
Sarcoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Indocyanine green solution administered at 2.0mg/kg.
Stryker SPY-PHI Imaging Device
Brief summary:
Conditions
Sarcoma
Study ID
NCT04719156
Start date
Mar 2, 2021
Status verified date
Feb, 2026
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
110 participants
Anticipated
Intervention Model
Single group
Primary purpose
Diagnostic
Arms
other: ICG use followed by SPY-PHI imaging.
Interventions
Indocyanine green solution administered at 2.0mg/kg.
Stryker SPY-PHI Imaging Device
Primary outcome measure
Central contacts
Locations
UPMC-Shadyside Hospital
Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contacts
Beata Krawczyk, MS
412-802-4100Sponsor
Kurt Weiss
Last update posted
Feb 20, 2026
Last verified
Feb, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Kurt Weiss on 2026-02-20.